Tag Archives: #fdasm

Shoot First, Apologize Later: Why Pharma Needs to Proceed without Social Media Guidelines

by DJ Edgerton (@wiltonbound) Like Tom Petty sang, the waiting is the hardest part. But is it necessary for pharma to continue holding out for social media guidelines before implementing digital...
Posted in Social Media | Tagged , , , , , , , | 4 Comments

Revolution meets reform: can social media help shrink health disparities in the United States?

By Jim Mittler, PhD, Medical Director (@jim_mittler) We all know that the social media revolution is happening and it cannot be stopped¢‚Ǩ"this is according to the exponential growth of...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , , , , , | 7 Comments

Amy Cowan of Google on All Things Digital and Pharma

Live From the E-Pharma Summit (#epharma) Amy Cowan, Head of Industry, Health for Google talks to us about search, how physicians are using the Internet and what Google wants the FDA to know about...
Posted in Digital Health, Social Media | Tagged , , , , , , , , , , , , , , , , , , , | 3 Comments

Christiane Truelove on Waiting on the FDA

Live from the E-Pharma Summit (#epharma) Christiane Truelove of Med Ad News gives her take on how companies are dealing with social media while they're waiting for the FDA...
Posted in Social Media | Tagged , , , , , , , , , , , , , , | 4 Comments

Guy Mastrion on How Design Can Help Pharma Companies Communicate Better

Live from the E-Pharma Summit (#epharma) Guy Mastrion, co-founder of Pixels & Pills, explains how design can solve some of the communications challenges that social media poses for the FDA and...
Posted in Social Media | Tagged , , , , , , , , , , , , , , | 2 Comments

Steve Woodruff of Impactiviti on eHarmony and the FDA

Live from the E-Pharma Summit (#epharma) Steve Woodruff of Impactiviti talks about what it's like to be the "eHarmony of the Pharmaceutical industry" and why the FDA should stay away from...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , | 2 Comments

John Mangano of ComScore on the Importance of Metrics

Live from the E-Pharma Summit (#epharma) John Mangano of ComScore explains why metrics are becoming more and more important to Pharma companies and how they're impacting the FDA's thinking about...
Posted in Digital Health, Social Media | Tagged , , , , , , , , , | 2 Comments

Russ Ward of Pixels & Pills on Next Steps for the FDA

Live from the E-Pharma Summit (#epharma) We kick off our coverage of the E-Pharma Summit with an interview with one of our own. Russ Ward talks about the challenges facing the FDA and their...
Posted in Social Media | Tagged , , , , , , , , , , , , , , | 1 Comment

Pixels & Pills Takes It On the Road

By Sven Larsen (@zemoga) Following up on our successful coverage of the FDA hearings on social media, Pixels and Pills is heading down to the e-Pharma Summit in Philadelphia next week. We'll be...
Posted in Digital Health, Social Media | Tagged , , , , , , , , , , | Leave a comment

Is the FDA Getting Web Friendlier?

By Russ Ward (@russcward) The FDAs Transparency Blog recently unveiled a new initiative, a simple "FDA Basics site with general information about the agency. In addition to the Transparency Blog...
Posted in Social Media | Tagged , , , , , , , , , , , , | Leave a comment

Paul Roellig of BulletinNEWS on the FDA and Publishing

Paul Roellig, CEO of BulletinNEWS explains how restrictions on advertising and social media by the FDA could impact the medical publishing business and cut off valuable sources of information for...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Robert Winder of VuMedi Talks About HCP Concerns and the FDA’s Social Media Policies

Robert Winder, CEO of VuMedi talks about educating Health Care Professionals and how company concerns about FDA Regulations can actually impede information...
Posted in Social Media | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment